In patients with renal insufficiency who develop hyperphosphatemia, there is often accompanying hypocalcemia, elevated fibroblast growth factor-23 (FGF-23) levels, and decreased active vitamin D levels. This evidence concerns the gene FGF23 and Renal insufficiency.